<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Daedalus Therapeutics is developing disease-modifying therapies for Primary Sclerosing Cholangitis (PSC), a rare progressive liver disease with no approved treatments.">
    <title>Daedalus Therapeutics | Disease-Modifying Therapies for PSC</title>
    
    <!-- Favicon -->
    <link rel="icon" type="image/svg+xml" href="images/favicon.svg">
    <link rel="icon" type="image/png" sizes="96x96" href="images/favicon-96x96.png">
    <link rel="shortcut icon" href="images/favicon.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="images/apple-touch-icon.png">
    <link rel="manifest" href="site.webmanifest">
    
    <!-- Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="styles.css">
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar" id="navbar">
        <div class="nav-container">
            <a href="#" class="nav-logo">
                <img src="images/logo.png" alt="Daedalus Therapeutics" class="logo-dark">
                <img src="images/logo-white.png" alt="Daedalus Therapeutics" class="logo-light">
            </a>
            <button class="nav-toggle" id="nav-toggle" aria-label="Toggle navigation">
                <span></span>
                <span></span>
                <span></span>
            </button>
            <ul class="nav-menu" id="nav-menu">
                <li><a href="#about" class="nav-link">About</a></li>
                <li><a href="#disease" class="nav-link">PSC</a></li>
            </ul>
        </div>
    </nav>

    <!-- Hero Section -->
    <header class="hero" id="hero">
        <div class="hero-content">
            <h1>Advancing Disease-Modifying Therapies for Primary Sclerosing Cholangitis</h1>
            <p class="hero-subtitle">Targeting the root causes of biliary disease to change outcomes for patients</p>
            <a href="#about" class="btn btn-primary">Learn More</a>
        </div>
        <div class="hero-overlay"></div>
    </header>

    <!-- About Section -->
    <section class="section about" id="about">
        <div class="container">
            <div class="section-header">
                <h2>About Daedalus Therapeutics</h2>
                <div class="section-divider"></div>
            </div>
            <div class="about-content">
                <div class="about-text">
                    <p class="lead">We are a biotechnology company developing disease-modifying therapies for Primary Sclerosing Cholangitis (PSC), a rare and devastating liver disease with no approved treatments.</p>
                    <p>Based in Cambridge, Massachusetts, Daedalus Therapeutics operates as a resident company at LabCentral within the Kendall Square life sciences ecosystem.</p>
                    <p>Our long-term goal is to develop treatments that meaningfully alter the course of PSC — slowing or preventing progression to cirrhosis, reducing the risk of liver failure and malignancy, and improving outcomes for patients who currently have few options.</p>
                </div>
                <div class="about-stats">
                    <div class="stat-card">
                        <div class="stat-icon">
                            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M22 12h-4l-3 9L9 3l-3 9H2"/></svg>
                        </div>
                        <h3>Unmet Need</h3>
                        <p>Zero approved disease-modifying therapies for PSC</p>
                    </div>
                    <div class="stat-card">
                        <div class="stat-icon">
                            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="12" cy="12" r="10"/><path d="M12 6v6l4 2"/></svg>
                        </div>
                        <h3>Progressive Disease</h3>
                        <p>Liver transplantation remains the only life-extending intervention</p>
                    </div>
                    <div class="stat-card">
                        <div class="stat-icon">
                            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M16 21v-2a4 4 0 0 0-4-4H6a4 4 0 0 0-4 4v2"/><circle cx="9" cy="7" r="4"/><path d="M22 21v-2a4 4 0 0 0-3-3.87"/><path d="M16 3.13a4 4 0 0 1 0 7.75"/></svg>
                        </div>
                        <h3>Patient Impact</h3>
                        <p>Young to middle-aged adults facing a lifelong progressive disease</p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Disease Section -->
    <section class="section disease" id="disease">
        <div class="container">
            <div class="section-header">
                <h2>Primary Sclerosing Cholangitis</h2>
                <div class="section-divider"></div>
            </div>
            <div class="disease-content">
                <div class="disease-intro">
                    <h3>A Rare and Devastating Liver Disease</h3>
                    <p>Primary Sclerosing Cholangitis (PSC) is a rare, progressive cholestatic liver disease characterized by chronic inflammation and fibrosis of the bile ducts. The disease most often affects young to middle-aged adults and is strongly associated with inflammatory bowel disease.</p>
                </div>
                
                <div class="disease-details">
                    <div class="disease-card">
                        <h4>Disease Progression</h4>
                        <p>PSC follows an unpredictable but relentlessly progressive course. Over time, ongoing bile duct injury leads to biliary stricturing, cholestasis, secondary hepatic fibrosis, cirrhosis, portal hypertension, and ultimately liver failure. Patients with PSC also face a markedly elevated lifetime risk of cholangiocarcinoma.</p>
                    </div>
                    
                    <div class="disease-card">
                        <h4>The Treatment Gap</h4>
                        <p>Despite decades of investigation, there are currently no approved disease-modifying therapies for PSC. Prior therapeutic efforts have largely focused on bile acid composition, symptomatic endpoints, or downstream inflammatory markers, with limited evidence of durable impact on disease progression.</p>
                    </div>
                    
                    <div class="disease-card">
                        <h4>The Challenge</h4>
                        <p>A central challenge in PSC drug development has been the complexity of bile duct–centered pathology and the lack of translational models that directly connect molecular mechanisms to epithelial injury and fibrotic progression.</p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-logo">
                    <img src="images/logo-white.png" alt="Daedalus Therapeutics">
                </div>
                <div class="footer-text">
                    <p>&copy; 2026 Daedalus Therapeutics. All rights reserved.</p>
                    <p class="footer-tagline">Advancing disease-modifying therapies for Primary Sclerosing Cholangitis</p>
                </div>
            </div>
        </div>
    </footer>

    <script>
        // Navbar scroll effect
        const navbar = document.getElementById('navbar');
        const hero = document.getElementById('hero');
        
        function updateNavbar() {
            if (window.scrollY > 50) {
                navbar.classList.add('scrolled');
            } else {
                navbar.classList.remove('scrolled');
            }
        }
        
        window.addEventListener('scroll', updateNavbar);
        updateNavbar();

        // Mobile menu toggle
        const navToggle = document.getElementById('nav-toggle');
        const navMenu = document.getElementById('nav-menu');
        
        navToggle.addEventListener('click', () => {
            navMenu.classList.toggle('active');
            navToggle.classList.toggle('active');
        });

        // Close mobile menu on link click
        document.querySelectorAll('.nav-link').forEach(link => {
            link.addEventListener('click', () => {
                navMenu.classList.remove('active');
                navToggle.classList.remove('active');
            });
        });

        // Smooth scroll for anchor links
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function(e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    const navHeight = navbar.offsetHeight;
                    const targetPosition = target.offsetTop - navHeight;
                    window.scrollTo({
                        top: targetPosition,
                        behavior: 'smooth'
                    });
                }
            });
        });
    </script>
</body>
</html>
